2024 MRM Talks: Dr. Amy Wong and Sydney Joy
The MRM Network presents: the MRM Talks. Join us to learn more about stem cells and regenerative medicine. Our webinar series will showcase prominent scientists in the field, including MRM Principal Investigators and external guest speakers.
During each seminar, we will also showcase the work of one MRM Trainee, who will present alongside our guest speaker.
In this edition of the MRM Talks:
Dr. Amy Wong,
Scientist, Program of Developmental & Stem Cell Biology, Hospital for Sick Children
Assistant Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto
“Modeling human lung development and disease using induced pluripotent stem cells”
Ph.D. Candidate in the Martin Lab,
Meakins Christie laboratories, RI-MUHC, McGill University
“Mesenchymal Stromal Cells for the Treatment of Systemic Sclerosis-Related Lung and Skin Fibrosis”
THURSDAY, March 28, 2024
12:00 – 1:00 PM
VIRTUAL – Registration is required
About the speakers:
Dr. Amy Wong was one of the first to develop a method to generate mature airway epithelia from human pluripotent stem cells and is internationally recognized as a pioneer in using human induced pluripotent stem cells to model lung development and disease. Her lab aims to 1) understand the genetic networks and molecular factors regulating lung cell development and disease mechanisms; 2) identify and test emerging therapeutics for lung diseases such as CF and respiratory viral infections and; 3) create novel preclinical lung mimetics for disease modeling using bioengineering approaches. In 2023, she received the Marsha Morton CF Award for outstanding research in cystic fibrosis. In addition to running a successful research lab, she volunteers her time as Chair of the Stem Cell Network ECR Committee, Vice Chair of the SickKids Foundation National Grant program, Executive Council member for the SickKids CF Centre and serves as a Scientific Advisory Board Member for Specific Biologics Inc.
Sydney Joy is a second-year PhD student with the Division of Experimental Medicine at McGill. She completed her undergraduate degree in life sciences with a specialization in biomedical research from Queen’s University in 2022. Now, under the co-supervision of Dr. Ines Colmegna and Dr. James Martin, her work focuses on the therapeutic applications of mesenchymal stromal cells in systemic sclerosis.
We want to hear from you, and we welcome your suggestions for speakers!
If you are interested in hosting an invited speaker, please get in touch with us.